Enanta Pharmaceuticals, Inc. (ENTA)
$14.10+4.68%Close
BUYRECOVERY · day 48
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $410M
- Avg volume
- 200.1K
- Beta
- 0.93
- P/E (TTM)
- -5.85
- Short % float
- 10.23%
- Days to cover
- 17.7
- SI change
- +6.0%
- 1W
- +9.90%
- 1M
- +10.33%
- 3M
- +1.08%
- YTD
- -2.22%
- vs SPY 1W
- +11.09%
- vs SPY 1M
- +7.01%
- vs SPY 3M
- -1.32%
- vs SPY YTD
- -13.97%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CVSELLCapsoVision, Inc.CRISISQ 39$5.83-3.16%
- CBIOBUYCrescent Biopharma, Inc.RECOVERYQ -1$16.97-1.05%
- JANXBUYJanux Therapeutics, Inc.RECOVERYQ 12$18.60+6.96%
- NRXSSELLNeurAxis, Inc.BEARQ 15$6.07-1.30%
- BOLTSELLBolt Biotherapeutics, Inc.RECOVERYQ -39$3.74+1.91%
- ADGMBUYAdagio Medical Holdings, Inc.CRISISQ -22$0.59-9.23%
- CVRXSELLCVRx, Inc.CRISISQ -21$3.15+10.92%
- COSMSELLCosmos Health Inc.RECOVERYQ -3$0.21-4.55%
- ENSCBUYEnsysce Biosciences, Inc.CRISISQ -25$0.36-2.70%
- BNTXBUYBioNTech SERECOVERYQ 37$112.82-3.22%
- HCTISELLHealthcare Triangle, Inc.CRISISQ -27$0.84-4.55%
- FDMTBUY4D Molecular Therapeutics, Inc.RECOVERYQ 5$15.39-2.78%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
